Navigation Links
Karen Walton-Bowen Joins Abt Bio-Pharma Solutions, Inc., as Senior Director, Biometrics
Date:10/22/2008

CAMBRIDGE, Mass., Oct. 22 /PRNewswire/ -- Karen Walton-Bowen, M.Sc., C.Stat, a biostatistician with more than 20 years experience in the pharmaceutical and biotechnology industries, has joined Abt Bio-Pharma Solutions, Inc. (ABS), as Senior Director, Biometrics. An expert in clinical trials and regulatory submissions in all phases of clinical development across multiple therapeutic areas, Ms. Walton-Bowen's experience encompasses clinical operations, data management, programming, statistical support, and medical writing, both in the U.S. and in Europe. In addition to leading ABS' full service Biometrics team, she will work one-on-one with sponsors to provide sophisticated biostatistics and medical writing consulting services for registries and late-phase clinical trials.

"Karen's strong technical and project management skills will make her a 'go to' resource for our small- to medium-size clients who wish to extend their capabilities with direct access to an hands-on expert with broad and deep therapeutic area experience," said Dr. Kay Larholt, Vice President of Biometrics & Clinical Operations. "We also expect Karen to add value and strengthen our already accomplished Biometrics team as it continues to support all our clinical projects, including clinical trials and registries."

Prior to joining ABS, Ms. Walton-Bowen was most recently Senior Director of Clinical Operations, Biostatistical Analysis, and Reporting at Critical Therapeutics, Inc. Previously, she spent four years at Genzyme Corporation, where she led the Biometrics team in a successful BLA submission and FDA Advisory Panel approval of a drug for a rare life-threatening disease in children. Ms. Walton-Bowen also spent many years at Astra (in the US and Sweden) as a biostatistician working on different compounds in the respiratory business unit. During that time she submitted numerous NDAs and represented the company at FDA meetings and Advisory Panels.

Ms. Walton-Bowen was awarded her M.Sc. in Medical Statistics by the University of London and earned her B.S. degree with honors in Mathematics & Computing from South Bank University, London, England. She is a member of the Royal Statistical Society, American Statistical Association, Drug Information Association, and the Association of Clinical Research Professionals. Ms. Walton-Bowen's work has been published in leading journals including Statistics In Medicine, The Journal of Pediatrics, and Annals of Allergy, Asthma & Immunology. She was also a contributor to Biopharmaceutical Sequential Statistical Applications, an important textbook on interim analyses with contributions from industry leaders.

The ABS team has provided integrated strategic, research, and commercialization services to the pharmaceutical, biotechnology, medical device, and diagnostics industries for more than 20 years. The company specializes in demonstrating the value, safety, and efficacy of health technologies through prospective studies such as registries as well as through retrospective data analyses, models, and quantitative and qualitative research. ABS teams of senior, seasoned staff help sponsors develop their research agendas, successfully conduct their research programs, and communicate the results to internal and external audiences. Primary service offerings include biometrics, clinical trials, registries and other late-phase clinical studies, health economics and outcomes research, pricing and reimbursement, and strategic commercialization services. Previously known as Abt Associates Clinical Trials, the company was renamed Abt Bio-Pharma Solutions and established as a wholly owned subsidiary of Abt Associates in April 2008.


'/>"/>
SOURCE Abt Bio-Pharma Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Health Monitoring Systems Appoints Karen S. Dockrell As VP, Sales
2. Food and Beverage Giant Joins Kannapolis Research Center
3. Mark Sutherland Joins GenVault as Senior Vice President, Business Development
4. Chief Technology Officer Joins ACAMP
5. Charles C. Harwood, Jr., Joins Cellectar, Inc.s Board of Directors
6. Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines
7. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors
8. Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
9. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
10. GM Exec Joins Bio-Reaction Industries Board of Directors
11. Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Calif. , Feb. 11, 2016  Dovetail Genomics™ ... to its beta program for a planned metagenomic genome ... present the company,s metagenomic genome assembly method in a ... in Genome Biology & Technology conference in ... of these highly complex datasets is difficult. Using its ...
(Date:2/11/2016)... ... February 11, 2016 , ... Global Stem ... clinic in Quito, Ecuador. The new facility will provide advanced protocols and state-of-the-art ... around the world. , The new GSCG clinic is headed by four ...
(Date:2/10/2016)... is introducing a hybrid membership model which will provide ... joining or renewing through an organizational purchasing model. For ... employee in any size association or AMC office can ... benefits.   John H. Graham, IV , ... organizations of any size and their employees to gain ...
(Date:2/10/2016)... ... 2016 , ... Benchmark Research, a fully-integrated network of ... principal investigators (PI) to the roles of Chief Medical Officer, Clinical Research and ... Chu, a Benchmark Research PI in the Austin office, will assume the role ...
Breaking Biology Technology:
(Date:1/13/2016)... 2016 --> ... market report titled - Biometric Sensors Market - Global Industry ... 2023. According to the report, the global biometric sensors market was valued ... reach US$1,625.8 mn by 2023, expanding at a CAGR ... volume, the biometric sensors market is expected to reach ...
(Date:1/11/2016)... Jan. 11, 2016 Synaptics Incorporated (NASDAQ: ... today announced that its ClearPad ® TouchView ™ ... won two separate categories in the 8 th ... Best Technology Breakthrough. The Synaptics ® TDDI solution ... supply chain, thinner devices, brighter displays and borderless designs. ...
(Date:1/8/2016)... MANCHESTER, United Kingdom , Jan. 8, 2016   ... diagnostic products, today announced the closing of a $9 million ... Proceeds from the financing will be used to accelerate the ... for detecting early-stage pressure ulcers. United ... receiving CE Mark approval. The device,s introduction has been met ...
Breaking Biology News(10 mins):